| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1021507312 |
| P356 | DOI | 10.1038/379019A0 |
| P698 | PubMed publication ID | 8538735 |
| P50 | author | Bert Vogelstein | Q827502 |
| Kenneth W. Kinzler | Q28031580 | ||
| P2860 | cites work | Activation of the cryptic DNA binding function of mutant forms of p53. | Q40408305 |
| Tumour suppressors, kinases and clamps: how p53 regulates the cell cycle in response to DNA damage. | Q40422537 | ||
| Biochemical properties and biological effects of p53. | Q40525130 | ||
| Angiogenesis inhibitors generated by tumors. | Q40927698 | ||
| Essential role for p53-mediated transcription in E1A-induced apoptosis | Q41302308 | ||
| p53-dependent apoptosis in the absence of transcriptional activation of p53-target genes | Q41454039 | ||
| Induction of apoptosis in HeLa cells by trans-activation-deficient p53 | Q53461564 | ||
| Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1 | Q71644976 | ||
| Release of an inhibitor of angiogenesis upon induction of wild type p53 expression in glioblastoma cells | Q24306649 | ||
| p53 modulation of TFIIH–associated nucleotide excision repair activity | Q24336880 | ||
| P53, cell cycle control and apoptosis: Implications for cancer | Q28611435 | ||
| Mice Lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control | Q29616465 | ||
| Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours | Q29618396 | ||
| Radiation-induced cell cycle arrest compromised by p21 deficiency | Q29620237 | ||
| p53 binds single-stranded DNA ends and catalyzes DNA renaturation and strand transfer. | Q34972350 | ||
| Hypoxia induces accumulation of p53 protein, but activation of a G1-phase checkpoint by low-oxygen conditions is independent of p53 status. | Q36665942 | ||
| Activation of p53 sequence-specific DNA bindingby short single strands of DNA requires the p53 C-terminus | Q38294071 | ||
| p53 and its 14 kDa C-terminal domain recognize primary DNA damage in the form of insertion/deletion mismatches | Q38294077 | ||
| P433 | issue | 6560 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 19-20 | |
| P577 | publication date | 1996-01-01 | |
| P1433 | published in | Nature | Q180445 |
| P1476 | title | Life (and death) in a malignant tumour | |
| P478 | volume | 379 |
| Q62394984 | A cellular automaton model for tumour growth in inhomogeneous environment |
| Q40898740 | A molecular genetic model of astrocytoma histopathology |
| Q41009556 | A new role for hypoxia in tumor progression: induction of fragile site triggering genomic rearrangements and formation of complex DMs and HSRs |
| Q37184148 | Altered gene expression and miRNA expression associated with cancerous IEC-6 cell transformed by MNNG. |
| Q35128710 | An in vivo function for the transforming Myc protein: elicitation of the angiogenic phenotype. |
| Q34178915 | Angiogenesis in transgenic models of multistep carcinogenesis |
| Q34027278 | Apoptotic count as a guide for histological grading of carcinoma esophagus: a light microscopic study |
| Q78679366 | Atomic force microscopy reveals kinks in the p53 response element DNA |
| Q39549322 | Baculovirus p33 binds human p53 and enhances p53-mediated apoptosis. |
| Q51605061 | Calcium-dependent interaction of S100B with the C-terminal domain of the tumor suppressor p53. |
| Q71879826 | Cancer prevention, rodent high-dose cancer tests, and risk assessment |
| Q23918490 | Carcinogen macromolecular adducts and their measurement |
| Q35746304 | Chromosomal alterations in paired gastric adenomas and carcinomas |
| Q53286471 | Clinical features and molecular alterations of traditional serrated adenoma in sporadic colorectal carcinogenesis. |
| Q41003479 | Comparison of bax, waf1, and IMP dehydrogenase regulation in response to wild-type p53 expression under normal growth conditions |
| Q53094239 | Correlation of TNFAIP8 overexpression with the proliferation, metastasis, and disease-free survival in endometrial cancer. |
| Q45345449 | Direct transcriptional activation of human caspase-1 by tumor suppressor p53. |
| Q41731870 | Drosophila p53 is a structural and functional homolog of the tumor suppressor p53. |
| Q40223437 | Effects of oxygen on intrinsic radiation sensitivity: A test of the relationship between aerobic and hypoxic linear-quadratic (LQ) model parameters |
| Q73310299 | Ethanol-induced apoptosis in vitro |
| Q53034051 | Etiologic value of p53 mutation spectra and differences with histology in lung cancers. |
| Q53427542 | Evidence for a role of delayed death and genomic instability in radiation-induced neoplastic transformation of human hybrid cells. |
| Q37484749 | Evolution of p53 in hypoxia-stressed Spalax mimics human tumor mutation |
| Q36618912 | Expression of apoptosis regulatory proteins of the Bcl-2 family and p53 in primary resected non-small-cell lung cancer |
| Q40901853 | Fast control of DNA replication in response to hypoxia and to inhibited protein synthesis in CCRF-CEM and HeLa cells |
| Q42427926 | Fiber-specific molecular features of tumors induced in rat peritoneum |
| Q28303776 | Fields and field cancerization: the preneoplastic origins of cancer: asymptomatic hyperplastic fields are precursors of neoplasia, and their progression to tumors can be tracked by saturation density in culture |
| Q24554531 | Gadd45, a p53-responsive stress protein, modifies DNA accessibility on damaged chromatin |
| Q73602630 | Gastric cancer with mutator phenotype: molecular bases and mechanisms of progression |
| Q35551099 | Genetic and epigenetic alterations as hallmarks of the intricate road to cancer. |
| Q43738168 | Glucose catabolism in cancer cells: identification and characterization of a marked activation response of the type II hexokinase gene to hypoxic conditions |
| Q40830532 | Historical, current and future aspects of osteosarcoma treatment |
| Q40586891 | Homozygous deletions within the 11q13 cervical cancer tumor-suppressor locus in radiation-induced, neoplastically transformed human hybrid cells |
| Q35413576 | Human lung cancer and p53: the interplay between mutagenesis and selection |
| Q35037445 | In pursuit of a molecular mechanism for adaptive gene amplification |
| Q53622619 | Increased expression of histone deacetylase 2 is found in human gastric cancer. |
| Q40697887 | Increased radiosensitivity with chronic hypoxia in four human tumor cell lines |
| Q44194183 | Induction of multiple double-strand breaks within an hsr by meganucleaseI-SceI expression or fragile site activation leads to formation of double minutes and other chromosomal rearrangements |
| Q39691186 | Inhibition of histone deacetylase activity down-regulates urokinase plasminogen activator and matrix metalloproteinase-9 expression in gastric cancer |
| Q36847869 | Inosine-5'-monophosphate dehydrogenase is a rate-determining factor for p53-dependent growth regulation |
| Q24800065 | Invasion and metastasis in pancreatic cancer |
| Q54517113 | Investigation of two Wnt signalling pathway single nucleotide polymorphisms in a breast cancer-affected Australian population. |
| Q52881675 | Loss of FBXW7 is related to the susceptibility and poor prognosis of cervical squamous carcinoma. |
| Q37024045 | Low dose radiation and intercellular induction of apoptosis: potential implications for the control of oncogenesis |
| Q33347932 | Metastatic susceptibility locus, an 8p hot-spot for tumour progression disrupted in colorectal liver metastases: 13 candidate genes examined at the DNA, mRNA and protein level |
| Q74703072 | Mitochondrial bound type II hexokinase: a key player in the growth and survival of many cancers and an ideal prospect for therapeutic intervention |
| Q73262482 | Molecular biology in bladder cancer |
| Q33711590 | Molecular genetics, natural history and the demise of childhood leukaemia |
| Q73534491 | Molecular genetics, natural history and the demise of childhood leukaemia |
| Q46664230 | Molecular heterogeneity in prostate cancer: can TP53 mutation unravel tumorigenesis? |
| Q35065032 | Molecular pathogenesis and prognostic factors in endometrial carcinoma |
| Q29616471 | Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers |
| Q48026339 | Multisite phosphorylation and the integration of stress signals at p53. |
| Q27851503 | Mutations in residues of TP53 that directly contact DNA predict poor outcome in human primary breast cancer |
| Q41679881 | P53 expression in altered limbal basal cells of pingueculae, pterygia, and limbal tumors |
| Q40219930 | P53 in blind subterranean mole rats--loss-of-function versus gain-of-function activities on newly cloned Spalax target genes |
| Q30428556 | P53 mutations in tumours induced by intraperitoneal injection of crocidolite asbestos and benzo[a]pyrene in rats |
| Q24550772 | PUMA mediates the apoptotic response to p53 in colorectal cancer cells |
| Q33608783 | Polymorphisms of xenobiotic-metabolizing enzymes and susceptibility to cancer |
| Q41493684 | Potential of microsensor-based feedback bioactuators for biophysical cancer treatment |
| Q36181210 | Prospects for bioreductive drug development |
| Q40964578 | Protein kinase CK2-dependent regulation of p53 function: evidence that the phosphorylation status of the serine 386 (CK2) site of p53 is constitutive and stable |
| Q36568304 | Proteolysis by calpains: a possible contribution to degradation of p53. |
| Q41372654 | Reciprocal paracrine interactions between tumour cells and endothelial cells: the 'angiogenesis progression' hypothesis |
| Q31431060 | Redox regulation of p53 during hypoxia |
| Q35250784 | Relationship of hypoxia-inducible factor 1alpha and p21WAF1/CIP1 expression to cell apoptosis and clinical outcome in patients with gastric cancer |
| Q54569740 | Role of ribonucleotide reductase and deoxynucleotide pools in the oxygen-dependent control of DNA replication in Ehrlich ascites cells. |
| Q46132798 | Role of tyrosine kinases in tumor progression of the head and neck |
| Q61797773 | Serrated Lesions of the Colon-Rectum: A Focus on New Diagnostic Tools and Current Management |
| Q44111054 | Similar UV responses are seen in a skin organ culture as in human skin in vivo |
| Q40302707 | Staurosporine modulates radiosensitivity and radiation-induced apoptosis in U937 cells. |
| Q36326004 | Strand asymmetry of CpG transitions as indicator of G1 phase-dependent origin of multiple tumorigenic p53 mutations in stem cells |
| Q77520982 | The G1-phase growth-arresting action of interleukin-1 is independent of p53 and p21/WAF1 function |
| Q34414655 | The role of selection in progressive neoplastic transformation |
| Q36296721 | Tolerance of human MSH2+/- lymphoblastoid cells to the methylating agent temozolomide |
| Q41140281 | Tumor angiogenesis: a physiological process or genetically determined? |
| Q73129415 | Tumour suppressor genes and angiogenesis: the role of TP53 in fibroblasts |
| Q38202873 | Updates from the Intestinal Front Line: Autophagic Weapons against Inflammation and Cancer |
| Q37811421 | Wnt and Incretin Connections |
| Q82060983 | [Hypoxia: a therapeutic target] |
| Q28512737 | p202, an interferon-inducible modulator of transcription, inhibits transcriptional activation by the p53 tumor suppressor protein, and a segment from the p53-binding protein 1 that binds to p202 overcomes this inhibition |
| Q42509836 | p53 Homologue p63 represses epidermal growth factor receptor expression. |
| Q40855467 | p53 and c-Jun functionally synergize in the regulation of the DNA repair gene hMSH2 in response to UV. |
| Q74604690 | p53 and its homologues, p63 and p73, induce a replicative senescence through inactivation of NF-Y transcription factor |
| Q37195703 | p53 expression in pterygium in two climatic regions in Turkey |
| Q42544741 | p53 protein expression in peripheral lymphocytes from atrazine chronically intoxicated rats |
| Q80352970 | p53, Ki-67, and serum alpha feto-protein as predictors of hepatocellular carcinoma recurrence in liver transplant patients |
| Q28513003 | p73-deficient mice have neurological, pheromonal and inflammatory defects but lack spontaneous tumours |
Search more.